新型聚乙二醇水凝胶制备及性能分析

Development and characterisation of a noval polyethylene-glycol hydrogel

  • 摘要: 目的 构建具有良好机械性能、止血性能且快速成胶的新型聚乙二醇水凝胶。 方法 以聚乙二醇为基本结构,通过调控四臂聚乙二醇氨基聚合物、四臂聚乙二醇琥珀酰亚胺碳酸酯聚合物、四臂聚乙二醇苯甲醛比例,制备新型基于聚乙二醇的水凝胶。通过静态秒表-样本瓶倾斜法、扫描电子显微镜、溶胀性能试验和力学性能试验测试其基本理化性质,通过与小鼠成纤维细胞共培养及新西兰白兔肝穿刺止血试验研究其生物安全性和止血性能。 结果 制备的新型聚乙二醇水凝胶成胶时间短且可控。扫描电镜显示基于聚乙二醇新型水凝胶具有蜂窝状多孔结构,孔孔相连且均匀分布,孔径可以调控。溶胀性能测试显示,GEL-1、GEL-2、GEL-3平均溶胀率分别为1 540%、1 620%和1 780%。力学性能测试显示,随着CHO比例的增多,水凝胶的抗压能力减弱,但是当CHO占0.3份时,断裂压强仍然能够达到27 MPa。体外与小鼠成纤维细胞共培养显示,新型水凝胶对细胞生长无明显抑制作用,细胞毒性低。新西兰白兔肝穿刺止血试验显示,空白对照组的血量是实验组的3 ~ 8倍。 结论 新型水凝胶作为止血剂具有一定的临床应用前景,其在载药缓释、组织工程等领域的应用尚需进一步评价。

     

    Abstract: Objective To synthesis a new polyethylene glycol hydrogel with rapid gelation, good mechanical properties, and hemostatic potential. Methods Noval hydrogels were prepared by physically blending the polymers (4-arm-PEG-NH2, 4-arm-PEG-NHS and 4-arm-PEG-CHO) with polyethylene glycol (PEG) in varying ratios (GEL-1:1:1:0; GEL-2:1:0.7:0.3; GEL-3:1:0.5:0.5). The physicochemical properties were evaluated by vial tilting method, scanning electron microscopy (SEM), swelling tests and mechanical testing. In vitro cytotoxicity testing was done using the direct contact method by co-culture with mouse fibroblasts and quantitatively assessed by MTT assay. In vivo evaluation of hemostatic effect was carried out on rabbit liver parenchymal injury model with liver lobe excision. Results The gelling time of the new type of PEG hydrogel was short and adjustable. Scanning electron microscopy (SEM) showed that the novel hydrogel based on polyethylene glycol had a honeycomblike porous structure with pores connected and evenly distributed, and the pore size could be controlled. The average swelling ratios of GEL-1, GEL-2 and GEL-3 were 1 540%, 1 620%, and 1 780%, respectively. The mechanical property test showed that the compressive strength of the hydrogel decreased with the increase of the proportion of CHO, but the fracture stress was still 27MPa when the CHO accounted for 0.3. Co-culture with mouse fibroblasts in vitro showed that the new hydrogel had no obvious inhibitory effect on cell growth with low cytotoxicity. The new hydrogels demonstrated excellent hemostatic ability for 3-8 folds reduction in blood loss compared with the control. Conclusion The new hydrogel had a certain clinical application prospect as a hemostatic agent, and its application in the sustained-release drug delivery, tissue engineering and other fields need to be further explored.

     

/

返回文章
返回